MAPK8 and fatty liver disease: This, in turn, mitigates IR, hepatic steatosis, and inflammatory responses by inhibiting downstream JNK and NF-κB signaling pathways, ameliorates IR, and consequently attenuates hepatic steatosis and inflammatory responses (36).